# Risk: __Incomplete coverage of information in ontologies__ (PBN__Risk_1454)

## Property: has_RiskISO_Impact

* [Innovation, Creativity and research](../RiskISO/PBN__RiskISO_Purpose_2)

## Property: has_RiskTechnology

* [ontology-based approaches](../Technology/PBN__Technology_715)
* [literature mining](../Technology/PBN__Technology_716)

## Property: has_RiskSubject

* [scientists](../Stakeholder/PBN__Stakeholder_46)
* [researchers](../Stakeholder/PBN__Stakeholder_2)
* [healthcare professionals](../Stakeholder/PBN__Stakeholder_32)

## Property: has_RiskType

* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskISO_Purpose

* [Resilience](../RiskISO/PBN__RiskISO_Impact_2)

## Property: has_RiskOwner

* [developers](../Stakeholder/PBN__Stakeholder_637)
* [ontology experts](../Stakeholder/PBN__Stakeholder_941)

## Property: has_RiskMitigation

* [Identify missing information and develop logical relations linking drugs, coronaviruses, and conditions for drug efficacy.](../RiskMitigation/PBN__RiskMitigation_1966)

## Property: has_RiskName

Limits the thorough study and representation of drugs and vaccines in ontologies.

## Property: has_RiskDescription

Existing ontologies may not cover all the needed information for the study of anti-coronavirus drugs and vaccines.

## Property: has_RiskSource

* [he_cido_2020](../Article/PBN__Article_13)

## Property: has_RiskGBN

* [No](../RiskGBN/PBN__RiskGBN_0)

## Property: has_RiskHealth

* [nan](../RiskHealth/PBN__RiskHealth_6)

